Dupixent® (dupilumab) Recommended for EU Approval by the …
WEB13 hours ago · TARRYTOWN, N.Y. and PARIS, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the expanded approval of ...
Press Release: Dupixent recommended for EU approval by the …
WEB13 hours ago · Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old . Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen …
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEB13 hours ago · NEW YORK and MAINZ, GERMANY, SEPTEMBER 20, 2024 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) has recommended marketing ...
Press Release: Tolebrutinib demonstrated a 31% delay in time to …
WEB13 hours ago · *For participants receiving tolebrutinib. Houman Ashrafian, MD, PhD Head of Research & Development, Sanofi “With no treatment options currently available for the broad population of patients with secondary progressive multiple sclerosis, tolebrutinib has demonstrated its ability to delay disability by targeting underlying drivers of the disease.
Actualité des professionnels de santé | Santé log
WEB39€ TTC. / 7 Numéros. Format numérique. Format PDF ( revue imprimable ) Découvrez la revue. Santé log site dédié à l'actualité des professionnels de santé. Santé log apporte une information pertinente et de qualité sur l'actualité médicale.
Corza Medical Named to the 2024 MedTech Big 100 List
WEB2 days ago · WESTWOOD, Mass., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”), a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, is proud to announce its inclusion in the prestigious 2024 MedTech Big 100 list.This respected list, compiled annually by Medical Design & Outsourcing, recognizes the largest ...
7 Hills Pharma Safely Doses First Patient in Phase 1b/2a Clinical …
WEBHOUSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- 7 Hills Pharma Inc. (“7 Hills” or “7HP”), a clinical-stage pharma company advancing first-in-class integrin activators designed to safely enhance cancer immunotherapies, announced today that their first cancer patient has been safely dosed with alintegimod, an integrin-targeted agonist that may augment T cell activation and trafficking in ...
Au-delà de la perte de poids, des avantages cardiovasculaires
WEBSep 3, 2024 · JACC. Le sémaglutide améliore les résultats de santé cardiaque au-delà de la perte de poids, confirme cette série de nouvelles études qui précise l’impact positif sur la santé cardiovasculaire chez les patients à risque cardiovasculaire élevé. Ces données, publiées dans le Journal of the American College of Cardiology (JACC) et ...
Smart for Life Announces Update on Prospective Acquisitions
WEBAug 21, 2024 · Smart for Life is seeking profitable companies in the nutraceutical industry across the United States as well as prospective foreign acquisitions, preliminarily targeting companies with between $5 million and $25 million in annual revenue. We pursue targets that are committed to innovation, high quality standards, organic growth, and that have ...
Mieux décrypté par des analyses de sang des patients - santé log
WEBJan 20, 2024 · Cette actualité a été publiée le 20/01/2024 par Équipe de rédaction Santélog. Vous pouvez nous suivre sur : L’analyse sanguine de patients atteints révèle de nouvelles caractéristiques du COVID long : des modifications de certaines protéines sériques qui semblent en cause dans le développement du syndrome. Les résultats ...